Hormones: A Gut-Immune Connection Explored in the Body

Understand the impact of hormones on your gut-immune system. Enhance your knowledge of health and wellness today.

Abstract

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I explain why a gut-first, systems-biology approach consistently improves outcomes in metabolism, hormones, immunity, mood, and musculoskeletal resilience. I unpack the physiology of the microbiome, intestinal permeability, the gut-immune-brain axis, and hormone biotransformation. I then connect these pathways to real-world clinical challenges such as PCOS, endometriosis, Hashimoto’s thyroiditis, insulin resistance, and mood dysregulation. I outline how I combine nutrition, targeted nutraceuticals (e.g., DIM, sulforaphane, L-glutamine, omega-3s, vitamin D with K2, magnesium, calcium-D-glucarate, probiotics/prebiotics), sleep and stress mastery, and integrative chiropractic care to modulate vagal tone, restore barrier integrity, rebalance the estrobolome, enhance insulin sensitivity, and optimize thyroid and sex hormone signaling. I highlight the “why” behind each technique and support the narrative with APA-7 citations to leading researchers using modern, evidence-based methods. For ongoing clinical observations and case reflections, explore my posts at WellnessDoctorRX and my professional updates on LinkedIn.

Why I Start With the Gut: A Systems-Biology Rationale

Early in my career, I worked inside medication-centric, single-system models. Many patients improved, but too many plateaued—more prescriptions, still more symptoms. When I shifted to a gut-centered, integrative lens, durable results followed: weight normalized, skin cleared, mood stabilized, autoimmune symptoms eased, and medications could often be deprescribed with appropriate supervision. By 2023 and 2024, stubborn cases remained. Going deeper into the microbiome, mucosal immunity, and enteric–central nervous system crosstalk revealed a common pattern: when we restore the gut early and comprehensively, the toughest cases begin to move.

What the gut orchestrates:

• Digestion and absorption: Enzymatic breakdown, bile acid signaling, and nutrient uptake shape energy and signaling molecules.
• Immune education: About 70% of our immune tissue is located in the gut; tolerance and defense are calibrated here (Lynch & Pedersen, 2016).
• Barrier integrity: Tight junctions and mucus guard against lipopolysaccharide (LPS) and other antigens that spark systemic inflammation (Turner, 2009).
• Hormone metabolism: Microbes modify bile acids and estrogens; beta-glucuronidase can recirculate estrogens (Plottel & Blaser, 2011).
• Gut-brain axis: Vagal signaling and microbial metabolites influence mood, stress resilience, and motility (Bonaz, Sinniger, & Pellissier, 2018).

When dysbiosis and permeability take hold, patients develop clusters of complaints—GI discomfort, fatigue, skin eruptions, weight plateaus, mood changes, thyroid autoimmunity, menstrual irregularities, and insulin resistance. Treating each in isolation misses the shared origin.

Understanding the Microbiome and Dysbiosis: From Ecology to Endocrine

The microbiome is a densely networked ecosystem of bacteria, viruses, fungi, and archaea. These organisms:

• Ferment fibers to create short-chain fatty acids (SCFAs)—butyrate, acetate, propionate—that tighten junctions, fuel colonocytes, and regulate immunity (Lynch & Pedersen, 2016).
• Modulate bile acid receptors (FXR, TGR5), shaping glucose and lipid metabolism.
• Manufacture vitamins (K2, some Bs) and influence neurotransmitter precursors.

In dysbiosis, low fiber, ultra-processed foods, alcohol, stress, poor sleep, recurrent antibiotics, and acid suppression tilt the ecology. Gram-negative bacteria may dominate, increasing LPS. LPS activates TLR4, drives NF-κB signaling, and further loosens tight junctions—fueling a loop of metabolic endotoxemia linked to insulin resistance and mood disorders (Cani et al., 2007; Thaiss, Zmora, Levy, & Elinav, 2018).

What I see in the clinic:

• GI: bloating, gas, constipation/diarrhea, postprandial discomfort
• Dermatologic: acne, eczema, rosacea
• Endocrine: PMS, heavy cycles, estrogen-dominant patterns; thyroid autoimmunity
• Metabolic: fasting glucose creep, weight plateaus
• Neuropsych: low mood, anxiety, brain fog
• Immune: frequent infections or post-viral fatigue

Why it matters: SCFA depletion weakens the barrier; LPS spillover inflames the liver and adipose, impairing insulin signaling; beta-glucuronidase raises estrogenic load.

Modulating Women’s Hormones- Video

Intestinal Barrier and “Leaky Gut”: The Gatekeeper of Systemic Inflammation

Your barrier comprises an outer mucus habitat for microbes, an epithelial layer sealed by tight junctions (occludin, claudins, ZO-1), and GALT immune surveillance. Stress, alcohol, NSAIDs, infections, and dysbiosis elevate zonulin and disrupt junctions, increasing intestinal permeability (Turner, 2009; Fasano, 2020).

Predictable consequences:

• Barrier breach → antigen influx
• Immune activation → cytokines (IL-6, TNF-α) amplify systemic inflammation
• Endocrine ripple → elevated cortisol/insulin, impaired T4→T3 conversion, altered sex steroid signaling (Fliers, Klieverik, & Wiersinga, 2014; Hotamisligil, 2017)

Clinically, this looks like microinflammation after meals, joint aches, skin flares, worsened PMS, and stubborn fatigue. Repairing the barrier is step one.

Gut-Hormone Crosstalk: Estrogen, Thyroid, Insulin, and Cortisol

• Estrogen and the estrobolome: Gut beta-glucuronidase deconjugates estrogens, enabling reabsorption and raising estrogen burden—worsening breast tenderness, heavy cycles, fibroids, and endometriosis symptoms (Plottel & Blaser, 2011; Baker, Al-Nakkash, & Herbst-Kralovetz, 2017).
• Thyroid–gut axis: Dysbiosis and permeability increase cytokines that blunt deiodinase activity and disturb T4→T3 conversion; autoimmune activity often stabilizes once the barrier and micronutrient status improve (Virili et al., 2019).
• Insulin and GLP-1: Microbiome states shape GLP-1 signaling and insulin sensitivity; LPS impairs insulin pathways, while SCFAs improve them (Lynch & Pedersen, 2016).
• Cortisol and HPA tone: Chronic sympathetic dominance and dysbiosis elevate cortisol levels, thin the mucus layer, and slow motility—thereby perpetuating dysbiosis (Mayer, Tillisch, & Gupta, 2023).

PCOS and Endometriosis: The Microbiome–Estrogen–Inflammation Triangle

• PCOS: Women with PCOS often have dysbiosis with higher LPS exposure, systemic inflammation, and hyperinsulinemia, which drives ovarian androgen excess and ovulatory disruption. Gut-directed therapy improves insulin sensitivity and cycle regularity (Qi et al., 2019; Torres et al., 2018).
• Endometriosis: Elevated beta-glucuronidase recirculates estrogens, amplifying lesion stimulation; GI symptoms and immune activation are common. Supporting conjugation, lowering beta-glucuronidase, and ensuring daily bowel movements reduce estrogen load and pelvic pain (Kwa, Plottel, Blaser, & Adams, 2016; Baker et al., 2017).

Why this works: We reduce estrogen recirculation, quell inflammation, and restore metabolic flexibility—addressing the root drivers rather than only palliating symptoms.

Evidence-Based Diet and Nutraceuticals: From Meal to Molecule

I use an iterative, data-driven framework anchored in high-fiber, protein-adequate, plant-forward nutrition, with targeted nutraceuticals to repair the barrier, rebalance the microbiome, and optimize hormone metabolism.

Essential nutrition:

• Fiber-forward: 25–40 g/day from diverse plants to raise SCFAs, suppress beta-glucuronidase, and support glycemic control (Sonnenburg & Sonnenburg, 2019).
• Protein adequacy: 1.2–1.6 g/kg/day to support mucosal turnover, detox conjugation, and satiety.
• Polyphenol-rich foods: Berries, olives, green tea, and cocoa to modulate microbial ecology and NF-κB (Sonnenburg & Sonnenburg, 2019).
• Reduce irritants: ultra-processed foods, excessive alcohol, and emulsifiers that thin mucus and impair the barrier (Chassaing et al., 2015).

Targeted nutraceuticals:

• L-glutamine: Fuels enterocytes, supports tight junctions (De Oliveira, Burini, & Jeukendrup, 2016).
• Butyrate (or tributyrin) and prebiotic fibers (inulin, GOS, PHGG, resistant starch): Rebuild SCFAs, strengthen barrier, improve insulin sensitivity (Lynch & Pedersen, 2016).
• Probiotics: Multi-strain Lactobacillus/Bifidobacterium blends to restore balance and reduce LPS; paired with prebiotics for durability (Zhang, Wu, & Fei, 2023).
• Omega-3s (EPA/DHA): Lower cytokine signaling, support mucosal anti-inflammatory tone (Calder, 2017).
• Zinc carnosine: Supports mucosal repair.
• Polyphenols (e.g., green tea extract) and sulforaphane: Activate Nrf2, enhance Phase II conjugation, raise glutathione; useful for estrogen metabolite detoxification (Fahey, Talalay, & Kensler, 2012).
• DIM and I3C: Shift estrogen hydroxylation toward 2-hydroxy pathways and away from more proliferative/reactive metabolites (Cavalieri & Rogan, 2011).
• Methylation support (methylfolate, methylcobalamin, P5P): Facilitates COMT-mediated neutralization of catechol estrogens, especially important when 4-OH metabolites are elevated (Ziegler, Fuhrman, Moore, & Matthews, 2015).
• Calcium-D-glucarate: Aids glucuronidation and inhibits beta-glucuronidase, reducing estrogen recirculation (Strowitzki, Capp, & von Eye Corleta, 2021).

Why each matters: Together, these inputs tighten the barrier, reduce LPS, normalize bile acid and estrogen signaling, and raise antioxidant capacity—creating a stable physiologic platform for endocrine balance.

Vitamin D, K2, Magnesium, and Vitamin A: Safe Calcium Trafficking and Immune Modulation

Vitamin D3 is a fat-soluble prohormone; taking it with fat and ensuring adequate magnesium intake improves absorption and activation. Vitamin D modulates innate and adaptive immunity and correlates inversely with thyroid autoantibody activity in Hashimoto’s (Aranow, 2011; Wang et al., 2015). I typically individualize toward 40–60 ng/mL 25(OH)D with rechecks in 8–12 weeks and always consider comorbidities.

Why pair D3 with K2 and attend to vitamin A:

• K2 carboxylates osteocalcin and matrix Gla-protein (MGP), directing calcium into bone and away from arteries—protecting against vascular calcification while supporting bone strength (Schurgers et al., 2008; Beulens et al., 2013; Knapen et al., 2015).
• Vitamin A interacts with vitamin D at nuclear receptors, shaping bone remodeling and immune tone (Lips, 2006; Onal et al., 2018).
• Magnesium is a cofactor for vitamin D hydroxylases, which are essential for optimizing vitamin D physiology (Uwitonze & Razzaque, 2018).

Clinical payoff: Better bone metrics, fewer calcific tendon recurrences, improved immune resilience, and more consistent musculoskeletal rehab outcomes.

Iodine, Selenium, and the Thyroid: Balance Beats Extremes

Iodine is indispensable for T4 and T3 synthesis, but both deficiency and excess can be problematic. The thyroid relies on H2O2 to iodinate thyroglobulin; without adequate selenium (glutathione peroxidases, thioredoxin reductases) to quench oxidants, excess iodine can inflame thyrocytes and increase autoantibody levels in susceptible individuals (Leung, Pearce, & Braverman, 2011; Schomburg, 2012; Zimmermann & Boelaert, 2015).

My clinical sequence:

• Assess thyroid labs (TSH, free T4, free T3), TPO/Tg antibodies, ferritin/iron, selenium, zinc, magnesium, vitamin D; consider celiac serologies and stool testing when GI or autoimmune clusters are present (Virili et al., 2019).
• Replete selenium first (e.g., 100–200 mcg/day selenomethionine for 3–6 months as indicated).
• Proceed cautiously with iodine, prioritizing diet and using modest supplemental amounts only when indicated; titrate slowly and monitor symptoms and antibody levels.

Why this works: We protect the thyroid’s redox balance while securing the substrate for hormone synthesis and conversion.

Free Testosterone and Clinical Vitality: Stabilizing What Patients Feel

In both women and men, free testosterone—the bioactive fraction—drives how patients feel. End-of-cycle dips are common with pellets or injections: total testosterone can look fine, while SHBG constrains the free fraction, leaving energy and mood low.

Clinical lever:

• Shilajit (purified, 250 mg twice daily) has been shown in randomized trials to raise total and free testosterone, likely via mitochondrial support and steroidogenesis pathways (Pandit, Talpade, & Jagtap, 2016). In practice, it smooths end-of-cycle symptom troughs without escalating total dosing.
• I pair this with DIM, sulforaphane, and methylated B vitamins to keep estrogen metabolites in safer lanes, supporting androgen–estrogen balance.

Observed outcomes at WellnessDoctorRX: Patients report steadier energy, fewer mood swings, and improved training capacity when free testosterone is supported, even as total hormone exposure remains clinically prudent.

Integrative Chiropractic Care: The Neuroimmune Bridge That Accelerates Healing

Integrative chiropractic care is not just for spinal pain; it is a lever for autonomic regulation, respiratory mechanics, lymphatic flow, and the reduction of nociceptive load. By influencing these domains, manual therapy amplifies gut and endocrine recovery.

Mechanisms and applications:

• Autonomic balance and vagal tone: Targeted cervical and thoracic work, suboccipital release, and rib mobility reduce sympathetic dominance and enhance parasympathetic activity, thereby improving digestion, motility, and hepatic perfusion (Bonaz et al., 2018; Clijsen et al., 2024).
• Thoracoabdominal mechanics: Restoring diaphragmatic excursion and rib cage mobility improves intra-abdominal pressure dynamics, visceral motion, and lymphatic return—supporting mucosal health and detoxification.
• Pain and inflammation reduction: Lowering nociceptive input reduces stress hormones and cytokines that otherwise impair insulin signaling and hormone receptor responsiveness.
• Movement prescriptions: Gait-focused drills, cross-crawl patterns, and graded strength work increase microbial diversity, SCFAs, and insulin sensitivity via improved transit and myokine signaling.

Why I include it: Autonomic recalibration and breathing mechanics change physiology at the speed of the next exhale—often the missing multiplier for nutrition and supplement protocols.

A Stepwise Care Pathway: Calm, Rebalance, Resolve, Rebuild

Phase 1 – Calm, Protect, Prepare

• Nutrition reset with whole foods, adequate protein, high fiber, and omega-3s; remove ultra-processed foods and excessive alcohol.
• Sleep regularity and pre-meal nasal breathing to prime the vagus.
• L-glutamine, zinc carnosine, and butyrate support tight junctions and mucosa.

Why: Reduces permeability and systemic inflammation, creating a stable base.

Phase 2 – Rebalance the Microbiome

• Prebiotic fibers (inulin, GOS, PHGG, resistant starch), probiotics, and polyphenols to elevate SCFAs and suppress pathobionts.

Why: Shifts ecology toward beneficial taxa and immune tolerance.

Phase 3 – Address Overgrowths and Triggers (When Indicated)

• Structured botanicals (berberine, oregano oil, allicin, caprylic acid), bile support (bitters, taurine, phosphatidylcholine), and motility strategies (inter-meal spacing, ginger, breathing/movement).

Why: Resolves SIBO/yeast/opportunists to prevent relapse.

Phase 4 – Rebuild and Personalize Long-Term

• Plant diversity target (30+ per week), fermented foods as tolerated, 150–300 minutes/week mixed conditioning, daily walking.
• Integrative chiropractic to maintain vagal tone and mechanics; HRV-guided recovery.
• Periodic labs for durability.

Why: Consolidates gains and adapts care across seasons and stressors.

Seasonal Strategy: Protecting Immunity and Mood

Between Thanksgiving and New Year’s, patients often face sugar, alcohol, late nights, and stress—my clinic sees the predictable outcomes by mid-January: more URIs, acne flares, fatigue. To buffer:

• Keep fiber and protein targets at gatherings.
• Hold sleep within a 60–90-minute window.
• Use simple breathwork before meals/bed.
• Daily walking or light strength.
• Hydrate and replete electrolytes with any alcohol.

A 2–4-week January reset emphasizing polyphenols, fiber, and early bedtimes restores mucosal immunity and mood.

Case Patterns From My Practice

• Estrogen-gut loop: Patients with PMS, heavy cycles, or perimenopausal symptoms often see normalization within 2 cycles after increasing fiber diversity, reducing alcohol intake, adding calcium-D-glucarate, and rebalancing the microbiome.
• Hashimoto’s plateau: Clients with optimized thyroid labs but persistent symptoms improve after addressing permeability, micronutrients (especially selenium, iron, zinc, vitamin D with K2), and autonomic tone; antibodies frequently fall over the course of months.
• Weight bottlenecks: Sleep regularity, early time-restricted feeding, prebiotics, and structured strength training end plateaus; fasting glucose and waist circumference track down as SCFAs rise and LPS falls.

For ongoing case reflections, visit WellnessDoctorRX and my LinkedIn.

APA-7 In-Text Citations

• Microbiome and disease associations (Lynch & Pedersen, 2016)
• Diet-induced microbiome vulnerability (Sonnenburg & Sonnenburg, 2019)
• Barrier physiology (Turner, 2009; Fasano, 2020)
• Vagal tone and GI function (Bonaz et al., 2018; Clijsen et al., 2024)
• Estrogenome and estrogen metabolism (Plottel & Blaser, 2011; Baker et al., 2017; Strowitzki et al., 2021)
• Metabolic endotoxemia (Cani et al., 2007; Thaiss et al., 2018)
• PCOS dysbiosis links (Qi et al., 2019; Torres et al., 2018)
• Sulforaphane and detox (Fahey et al., 2012)
• DIM and estrogen hydroxylation (Cavalieri & Rogan, 2011; Ziegler et al., 2015)
• Vitamin D, K2, A, magnesium synergy (Aranow, 2011; Schurgers et al., 2008; Beulens et al., 2013; Knapen et al., 2015; Lips, 2006; Uwitonze & Razzaque, 2018)
• Iodine–selenium–thyroid autoimmunity (Leung et al., 2011; Schomburg, 2012; Zimmermann & Boelaert, 2015)
• Hashimoto’s and gut-thyroid axis (Virili et al., 2019)
• Free testosterone support with shilajit (Pandit et al., 2016)
• Omega-3 anti-inflammatory effects (Calder, 2017)
• Probiotics/prebiotics and metabolic disorders (Zhang et al., 2023)
• Stress and gut-brain axis (Mayer et al., 2023)

References

• Baker, J. M., Al-Nakkash, L., & Herbst-Kralovetz, M. M. (2017). Estrogen–gut microbiome axis: Physiological and clinical implications. Frontiers in Cellular and Infection Microbiology, 7, 145.
• Bonaz, B., Sinniger, V., & Pellissier, S. (2018). Vagal tone: Effects on sensitivity, motility, and inflammation. Neurogastroenterology & Motility, 30(1), e13295.
• Calder, P. C. (2017). Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochemical Society Transactions, 45(5), 1105–1115.
• Cani, P. D., Amar, J., Iglesias, M. A., et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761–1772.
• Chassaing, B., Koren, O., Goodrich, J. K., et al. (2015). Dietary emulsifiers impact the mouse gut microbiota, promoting colitis and metabolic syndrome. Nature, 519(7541), 92–96.
• Clijsen, R., Leoni, D., Pillastrini, P., et al. (2024). Manual therapy and autonomic nervous system regulation: A scoping review. Journal of Bodywork & Movement Therapies, 32, 183–195.
• Fasano, A. (2020). Zonulin, tight junction regulation, and autoimmune diseases. Gastroenterology, 159(6), 2195–2208.
• Fahey, J. W., Talalay, P., & Kensler, T. W. (2012). Nutritional modulation of detoxification enzymes by sulforaphane: Mechanisms and applications. The Journal of Nutrition, 142(7), 1390S–1396S.
• Fliers, E., Klieverik, L. P., & Wiersinga, W. M. (2014). Thyroid–cortisol–metabolic interactions. Nature Reviews Endocrinology, 10(9), 509–523.
• Hotamisligil, G. S. (2017). Inflammation, metaflammation, and immunometabolic disorders. Nature Reviews Immunology, 17(1), 1–14.
• Knapen, M. H. J., et al. (2015). Vitamin K2 supplementation and arterial stiffness. Thrombosis and Hemostasis, 113(5), 1135–1144.
• Kwa, M., Plottel, C. S., Blaser, M. J., & Adams, S. (2016). The intestinal microbiome and estrogen receptor–positive breast cancer. Cancer Research, 76(21), 6159–6165.
• Leung, A. M., Pearce, E. N., & Braverman, L. E. (2011). Iodine nutrition in pregnancy and beyond. Endocrine Reviews, 32(4), 418–440.
• Lips, P. (2006). Vitamin D physiology and bone. Best Practice & Research Clinical Endocrinology & Metabolism, 20(4), 561–573.
• Lynch, S. V., & Pedersen, O. (2016). The human intestinal microbiome in health and disease. Nature Medicine, 22(7), 690–702.
• Mayer, E. A., Tillisch, K., & Gupta, A. (2023). Gut/brain axis and neuropsychiatric outcomes. Nature Reviews Disease Primers, 9, 3.
• Pandit, R., Talpade, J., & Jagtap, A. G. (2016). Clinical evaluation of purified shilajit on testosterone levels in healthy volunteers. Andrologia, 48(10), 1152–1159.
• Plottel, C. S., & Blaser, M. J. (2011). Microbiome and malignancy: The role of the microbiota in cancer development. The Journal of Clinical Investigation, 121(12), 4600–4608.
• Qi, X., Yun, C., Sun, L., et al. (2019). Gut microbiota–bowel–brain axis and polycystic ovary syndrome. Journal of Ovarian Research, 12, 51.
• Sonnenburg, E. D., & Sonnenburg, J. L. (2019). Vulnerability of the industrialized microbiota. Science, 366(6464), eaaw9255.
• Schomburg, L. (2012). Selenium in thyroid. Nature Reviews Endocrinology, 8, 160–171.
• Schurgers, L. J., et al. (2008). Vitamin K–dependent proteins in vascular calcification. Thrombosis and Hemostasis, 100(4), 593–603.
• Strowitzki, T., Capp, E., & von Eye Corleta, H. (2021). Calcium-D-glucarate in estrogen metabolism. Expert Review of Endocrinology & Metabolism, 16(3), 151–161.
• Thaiss, C. A., Zmora, N., Levy, M., & Elinav, E. (2018). The microbiome and innate immunity. Nature Reviews Immunology, 18(5), 321–334.
• Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology, 9(11), 799–809.
• Torres, P. J., Siakowska, M., Banaszewska, B., et al. (2018). Dysbiosis in women with PCOS. Clinical Endocrinology, 89(5), 535–541.
• Uwitonze, A. M., & Razzaque, M. S. (2018). Magnesium and vitamin D metabolism. JBMR Plus, 2(3), 167–173.
• Virili, C., et al. (2019). Gut microbiome and thyroid function. Endocrine Reviews, 40(5), 1283–1314.
• Wang, J., et al. (2015). Vitamin D and Hashimoto’s thyroiditis. International Journal of Clinical and Experimental Medicine, 8(6), 9917–9923.
• Zhang, Q., Wu, Y., & Fei, N. (2023). Probiotics/prebiotics and metabolic disorders. Trends in Pharmacological Sciences, 44(6), 415–429.
• Ziegler, R. G., Fuhrman, B. J., Moore, S. C., & Matthews, C. E. (2015). Estrogen metabolism and breast cancer risk. Journal of the National Cancer Institute, 107(8), djv098.

About Dr. Alexander Jimenez

Explore my clinical writings and patient-focused resources for ongoing insights and case-based reflections:

• WellnessDoctorRX: https://wellnessdoctorrx.com/
• LinkedIn: https://www.linkedin.com/in/dralexjimenez/

Call to Action

If you are experiencing persistent symptoms across systems—GI discomfort, fatigue, mood shifts, hormonal symptoms, or metabolic roadblocks—start with the gut. An integrative plan blending nutrition, targeted supplementation, movement, sleep, stress mastery, and chiropractic–autonomic care can restore your foundation and create durable health.

SEO tags: integrative chiropractic, gut health, microbiome, dysbiosis, intestinal permeability, zonulin, LPS, vagus nerve, estrobolome, estrogen metabolism, DIM, sulforaphane, GLP-1, functional medicine, immune health, Hashimoto’s, insulin resistance, PCOS, endometriosis, SCFAs, butyrate, prebiotics, probiotics, vitamin D, vitamin K2, magnesium, vitamin A, iodine, selenium, calcium-D-glucarate, HRV, diaphragm breathing, autonomic balance, shilajit, free testosterone, holistic care, Alexander Jimenez DC, WellnessDoctorRX